Uses of pegylated albumin
US8071546B2 · kind B2 · utility
1Cited by
16References
27Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 9, 2006 |
| Grant date | Dec 6, 2011 |
| Priority date | — |
| Expiry date | Apr 24, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to uses of PEGylated albumins which include methods of treating reduced functional capillary density, reduced blood volume, septic shock and cardiac arrhythmia in a subject, which comprise administering to the subject a therapeutically effective amount of a PEGylated albumin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.